Key result
Isoproterenol administration induced a significantly greater percentage increase in heart weight/bodyweight ratio in A/J mice compared to B6 mice (24% vs 3%; P<0.001).
RCT (n=39)
randomly assigned
In a mouse model of isoproterenol-induced cardiac hypertrophy, B6 mice demonstrate less hypertrophy but greater basal activity of key metabolic enzymes compared to A/J mice, suggesting strain-specific metabolic adaptations.
Mouse strain differences suggest metabolic enzyme activity modulates hypertrophy; hypothesis-generating for genetic modifiers, not yet clinically relevant.
Alterations in myocardial energy metabolism accompany pressure overload-induced hypertrophy. We previously described a novel model of catecholamine-induced hypertrophy in which A/J mice exhibit more robust cardiac hypertrophy than B6 mice. Accordingly, we assessed the influence of mouse strain on the activities of key myocardial metabolic enzymes and whether there are strain-related metabolic adaptations to short-term, high-dose isoproterenol (ISO) administration. 2. Thirty-nine male mice (19 A/J mice, 20 B6 mice), aged 12-15 weeks, were randomly assigned to receive either ISO (100 mg/kg, s.c.) or vehicle (sterile water) daily for 5 days. On Day 6, all hearts were excised, weighed, freeze clamped and assayed for pyruvate dehydrogenase (PDH), medium chain acyl-CoA dehydrogenase, carnitine palmitoyl transferase I and citrate synthase activities. Plasma fatty acids (FA) were also measured. 3. The ISO-treated A/J mice demonstrated greater percentage increases in gravimetric heart weight/bodyweight ratio than ISO-treated B6 mice (24 vs 3%, respectively; P < 0.001). All enzyme activities were significantly greater in vehicle-treated B6 mice than in A/J mice, illustrating a greater capacity for aerobic metabolism in B6 mice. Administration of ISO reduced PDHa (active form) activity in B6 mice by 47% (P < 0.001), with no significant change seen in A/J mice. Free FA levels were not significantly different between groups; thus, the differences in PDHa were not due to changes in FA. 4. The basal activity of myocardial metabolic enzymes is greater in B6 mice than in A/J mice and ISO alters myocardial PDH activity in a mouse strain-dependent manner. Compared with A/J mice, B6 mice demonstrate less ISO-induced cardiac hypertrophy, but greater activity of key enzymes regulating FA and carbohydrate oxidation, which may protect against the development of hypertrophy. The metabolic adaptations associated with ISO-induced hypertrophy differ from those reported with pressure overload hypertrophy.
No takes yet. Share an insight, caveat, or question.
Faulx et al. (2006) conducted an RCT in isoproterenol-induced cardiac hypertrophy (n=39). Isoproterenol vs. Vehicle (sterile water) was evaluated on percentage increase in gravimetric heart weight/bodyweight ratio (p=<0.001). Isoproterenol administration induced a significantly greater percentage increase in heart weight/bodyweight ratio in A/J mice compared to B6 mice (24% vs 3%; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: